Official Twitter account for Pharmaceutical Executive, a digital and print magazine offering news and opinions, analysis, features and executive profiles.
London & New Jersey
- Tweets 26,103
- Following 598
- Followers 34,734
- Likes 4,174
Pinned Tweet
🚨Our March issue is LIVE🚨
Learn about immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics in our cover profile🔷 Sourcing, nurturing, and retaining talent🔷Making HCP analytics actually work for commercial teams🔷and much more right here➡️pharmexec.com/journals/pharm…
3
3
7
3,024
China's biotech licensing deals hit $51.9 billion in 2024, up 90% year over year.
Dr. Ying Huang, CEO of K2 Therapeutics, on what's fueling the shift.
🔗 Watch more: hubs.li/Q04y9Md-0
#PharmExec #Biotech
278
Agentic AI is reshaping the specialty pharmacy experience. Explore how Gifthealth combines intelligent automation with human expertise to streamline the prescription journey while keeping empathy, clinical judgment, and trust at the center. #HealthTech
hubs.li/Q04x4fV10
280
As specialty therapies become more complex, patient support must evolve beyond individual services. Discover how connected technology and human engagement can create a more coordinated, personalized patient experience. #PatientSupport
hubs.li/Q04xpXPB0
1
2
289
An executive order can cut drug prices today & get undone tomorrow.
Joe Cunningham says the new MFN deals are a good first step, but without Congress behind them, they only touch Medicaid, leaving the commercial market, about 80% of Americans, untouched.
#PharmExec #DrugPricing
1
306
Onshoring pledges & a shifting FDA pricing conversation are reshaping how pharma leaders plan ahead.
Latest Fault Lines Peer Exchange: hubs.li/Q04xMjW60
#PharmaExec
2
281
Real-world data used to be a nice-to-have in pharma research.
Mark Cziraky, President of Carelon Research, says that's changing fast.
🔗 Watch the full conversation: hubs.li/Q04xw_6_0
#PharmExec #RealWorldData
1
325
Eli Lilly leads the 2026 Pharm Exec Top 50 for the first time ever.
See how the rest of the top 10 stacks up.
🔗 Full rankings: hubs.li/Q04wDYYl0
#PharmExec #PharmaTop50
1
4
342
If the FDA restricts compounded peptides without a clear regulated pathway, where does that demand actually go?
Nate Hill, CEO of Strive Pharmacy, on the gray market's biggest blind spot.
Watch part one➡️ hubs.li/Q04vYS910
#PharmExec #Peptides #Compounding
1
546
Licensing commitments with Chinese companies hit a record $51.9B in 2024, up 90% in a single year.
K2 Therapeutics CEO Ying Huang on the two forces that made the shift permanent: hubs.li/Q04vykhT0
#PharmExec #Biotech
1
418
What's pushing doctors out of clinical practice before 50? New research in The Permanente Journal offers the clearest picture in over a decade, and points to a factor the burnout conversation keeps missing.
hubs.li/Q04rDW_r0
#PhysicianBurnout #ClinicalPractice
339
Peter Friedman (LiveWorld) on why human-led AI is essential for pharma navigating hallucination risk and regulatory scrutiny, and how curated data plus human expertise turns raw information into decision-grade insight.
hubs.li/Q04sL_j10
#AIinPharma #LiveWorld
1
409
An FDA panel just recommended six peptides for the compounding Bulks List.
James LaValle says that is not approval, & the real fight is over evidence & oversight.
🔗 Full Q&A: hubs.li/Q04t_Qmc0
#PharmExec #PeptideTherapy
405
Only 9% of the API used in U.S. drugs is actually made here, even though generics fill about 90% of prescriptions.
Rohit Tripathi explains why reshoring pharma takes more than a new factory.
🔗 Full Q&A: hubs.li/Q04tQjts0
#PharmExec #Reshoring
1
2
371
Real-world data is reshaping clinical trials — but the richest insights are often locked in unstructured clinical notes. See how AI is changing that. New research from Tufts CSDD
Register now: hubs.li/Q04qHG_B0
1
2
359
The gap between biopharma companies with connected, structured data and those without keeps widening. Danny Sigurdson (Courier Health) on harnessing AI to orchestrate more seamless patient experiences.
hubs.li/Q04rSryJ0
#PatientExperience #AIinPharma
316
The mean age physicians leave clinical practice has dropped to 48.1, down from 57.1 a generation ago, per a national survey of nearly 1,000 inactive doctors. Scientific overload may be the next burnout crisis.
hubs.li/Q04rD7-k0
#PhysicianBurnout #Healthcare
1
311
Real-world data is reshaping clinical trials — but the richest insights are often locked in unstructured clinical notes. See how AI is changing that. New research from Tufts CSDD
Register now: hubs.li/Q04qHYrz0
1
324
The calls. The quotes. The perspectives shaping pharma's biggest conversations before they hit the headlines.
Managing Editor Mike Hollan unpacks it all on Exec on Execs.
Watch the latest episode: hubs.li/Q04ssRNr0
#Pharma #ExecOnExecs #PharmExec #PharmaLeadership
1
376
China's biotech surge isn't a surprise.
It's the result of two decades of deliberate investment modeled on the same playbook that gave the U.S. four decades of biomedical leadership.
👉 John Stanford of Incubate on what the U.S. should do next: hubs.ly/Q04s8dMJ0
#Pharma #Biotech #PharmExec
2
1
374
Jason Rains & Randy Quist (Inizio Engage) on an end-to-end patient support model built on 25 years of nurse clinical education experience, using a non-dispensing pharmacy and smart automation to streamline access and prior authorization.
hubs.li/Q04q8jvC0
#PatientAccess #SpecialtyPharmacy
421